ShettleL, MulaneyJ, WilliamsRD, et al.Double-masked controlled trial of H-1337 as a treatment for glaucoma and ocular hypertension. J Ocul Pharmacol Ther2026;42(2):83–91.
2.
Anonymous. Commissioner’s National Priority Voucher (CNPV) pilot program; public hearing; request for comments. Fed Reg2026;91:13849–13852.
